Abstract
Lung transplantation has evolved into a life-saving therapy for patients with advanced lung diseases. Success rates after lung transplantation are largely due to advances in immunosuppressive therapies that have enabled transplant recipients to maintain lung allograft function with decreased acute and chronic rejection. However, it is unclear if any particular immunosuppressive therapy is better for decreasing rejection and improving survival after lung transplant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
